Sanjeevan Muruganandan

Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial

Sanjeevan Muruganandan, Maree Azzopardi, Deirdre Fitzgerald et al. · The Lancet Respiratory Medicine · 2018 · 209 citations · Full text

Medicine, Surgery, Hemodynamic Management +13

The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion

Sanjeevan Muruganandan, Maree Azzopardi, Rajesh Thomas et al. · European Respiratory Journal · 2020 · 79 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters

Maree Azzopardi, Rajesh Thomas, Sanjeevan Muruganandan et al. · BMJ Open · 2016 · 36 citations · Full text

Medicine, Surgery, Cancer Control +16

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma

Sanjeevan Muruganandan, Helman Alfonso, Peter Franklin et al. · British Journal of Cancer · 2017 · 33 citations · Full text

Veterinary Medicine, Oncology, Pathology +10

A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma

Wei‐Sen Lam, Jenette Creaney, Fred K. Chen et al. · Lung Cancer · 2019 · 29 citations

Medicine, Oncology, Pharmacology +15